Erik Lefkofsky was recently featured in the Ideamensch interview which discussed the origins of Tempus. Erik Lefkofsky began Tempus to create a more personalized treatment plan for patients who have cancer. This machine learning platform allows physicians to have a better understanding of the disease. Lefkofsky is also known for co-founding Groupon, an e-commerce website that provides coupons on various activities around the world.
However, Erik Lefkofsky is a serial entrepreneur. He began Uptake Technologies and Mediaocean, technology companies that provide integrated media and analytics. He also started companies like Lightbank which uses investing to disrupt the technology world.
He started Tempus after his own personal experience watching a loved one go through the treatment process for cancer. The physicians were not able to access the data and technology that are available to so many other industries. This was the beginning of a personal quest to help provide data to cancer patients in a clinical setting.
Lefkofsky is one of the few that does not have a typical day in the office. However, he does try to be the first one in the office to work before other people start demanding his time. He focuses on problem management. Building the company requires input and time form the CEO and co-founder that can be exciting but also draining. He began working form home on Fridays to help him stay productive.
Erik Lefkosky believes ideas work the best when they are solutions. He and his business partner want to create solutions to the world’s problems and believes that creating new ideas just for the idea’s sake is wasteful. They have begun more than six companies over the past two decades and they have discovered the key to success is quite simple. They simply need to identify a big enough problem and discover a solution.
One trend that really excites Erik Lefkofsky is Biotech. He believes that technology can create a huge paradigm shift in the way we live, particularly when we start implementing technology into the way we treat the body. Though the body has been subject to the same diseases for thousands of years, the improvements in technology are creating new solutions.